Tomorrow belongs to the daring
We are Earlybird Venture Capital, optimistic risk-takers who roll up their sleeves
Our Founders
Valentin Stalf & Maximilian Tayenthal, CEO & COO
Earlybird played a crucial role in shaping our vision and market strategy, especially during our Seed and Series A stages. They have proven to be enormously valuable sparring partners.
Sidar Sahin, CEO
Earlybird shared our vision — that global B2C technology companies can be built in Europe — and invested in Peak Games at a time when there were not many examples on the continent.
Olivier Delporte, CEO
I have received fantastic support from the Earlybird team. Whether for financing purposes, operational issues or strategy, their polyvalent healthcare team has always been there for Miracor. They provide relevant input and always remain solution-oriented. It has been — and continues to be — a pleasure to have them as a key investor.
Greg Luck, CTO
Roland from Earlybird has been very hands-on as a director of Hazelcast. His efforts have been extremely helpful in introducing Hazelcast to partners and sales opportunities.
About Us
Earlybird is a venture capital investor focused on European technology innovators.
Founded in 1997, Earlybird invests in all development and growth phases of technology companies. Among the most experienced venture investors in Europe, Earlybird offers its portfolio companies not only financial resources, but also strategic and operational support, as well as access to an international network and capital markets.
Earlybird Venture Capital has grown to three autonomous, dedicated and specialized teams, focusing on different geographies and sectors.
The Digital West Fund focuses primarily on early stage digital technology opportunities in GSA, Nordics, UK, Benelux, France and Southern Europe, while the Digital East Fund is focused on early stage ICT investment opportunities in Eastern Europe and Turkey, being the leading tech VC in this region. The Health Fund focuses on early and later stage opportunities in digital health, medical devices, diagnostics, enabling technologies and biopharma across Europe.
With over EUR 1 billion under management, seven IPOs and 24 trade sales, Earlybird is one of the most successful venture capital firms in Europe. Beyond delivering financial returns, we clearly see our own entrepreneurial responsibility for the environment as well as society and strive to make a positive contribution towards solving the global climate crisis. We are committed to running our own operations in a more eco-sustainable way and offset the residual carbon-footprint while expecting the same from our Portfolio-Companies.
1
BILLION EUROS OF ASSETS UNDER MANAGEMENT
34
INVESTMENTS IN THE LAST 12 MONTHS
500
THOUSAND EUROS AS LOWEST INVESTMENT
47
PERMANENT EMPLOYEES
10
MILLION EUROS AS HIGHEST INVESTMENT
22
YEARS OF EXPERIENCE